OMEROS CORP — Investor Relations & Filings
Filings indexed
763
across all filing types
Latest filing
2026-04-30
Annual Report
Country
US
United States of America
Listing
US
OMER
Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company leverages innovative science to build a diverse pipeline of first-in-class drug candidates designed to address challenging diseases and disorders with significant unmet medical needs. Omeros concentrates on developing therapeutics with novel mechanisms of action that target previously untapped receptors and enzymes, aiming to provide next-generation treatments for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | |
| 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 39078996 | ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 39079103 | DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 33062212 | SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | ||
| 32700252 | 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | ||
| 28665560 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 28665570 | 4 Filing | 2026-01-14 | English | ||
| 28665565 | 8-K Filing | 2026-01-07 | English | ||
|
2025
8 filings
| |||||
| 11674670 | FORM 8-K | 2025-12-29 | English | ||
| 11674671 | FORM 8-K | 2025-12-01 | English | ||
| 11674672 | Prospectus 2025 | 2025-11-14 | English | ||
| 11674673 | Registration Form 2025 | 2025-11-14 | English | ||
| 11674674 | FORM 10-Q | 2025-11-13 | English | ||
| 11674675 | FORM 8-K | 2025-11-13 | English | ||
| 11674676 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 11674677 | FORM 4 | 2025-10-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
|
CG Oncology, Inc.
Develops bladder-sparing oncolytic immunotherapies for urol…
|
CGON | US | Manufacturing |
OMEROS CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33369/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33369 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33369 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33369 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33369}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OMEROS CORP (id: 33369)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.